Welcome to another Pinktober!

October is known as the worldwide awareness month of breast cancer. Previously, we have talked about how early detection and personalized cancer treatment plans are key factors in breast cancer control. The purpose of this year’s message is to focus on what can be done before? We’ll talk about some preventive measures which individuals can follow to take care of their well-being. 

Diversity Series: Serena & Loïc

HEMEX is pleased to introduce you to the new talented minds and charismatic personalities on the team! Are you curious? Then keep reading, because today you will learn more about our office manager and executive assistant Serena and our junior sales associate Loïc.

Comms&Media service for startups powered by Benz Advisory, mediacrewgroup, and HEMEX

Benz Advisory, mediacrewgroup, and HEMEX join forces to support early-stage companies with strategic communications through a new service called Comms&Media. Targeted at early-stage businesses from all industries, it offers a unique, holistic approach to help companies develop and implement effective external and internal communications.

How to bake a “delicious” pitch for investors?

Every Start-up knows the importance of a great pitch. Today we want to give you some advice on how to find out the essential ingredients to bake a delicious pitch which investors will enjoy every single bite. More importantly, leave them craving for more!

Resistell Announces Start Of Performance Evaluation Study

Resistell has started the Performance Evaluation Study (PES) of its groundbreaking nanomotion technology at Lausanne University Hospital. At HEMEX, are very happy to be part of this project, as we will be monitoring the clinical trial over the next 12 months.

Major milestone for Inura Medical, who closes pre-series A financing round

Inura Medical’s mission is to improve women’s health through the development of an urethral ovulum for the treatment of patients suffering from urinary bladder diseases. Their first pharmaceutical product is addressing an unmet medical need in overactive bladder (OAB). 

Our portfolio company HexagonFab secures CHF 2.5m seed funding

HexagonFab, a spin-out from the University of Cambridge, has developed a novel approach for drug discovery and production process monitoring called the Bolt. This innovative device is an analytical lab instrument that provides convenient and affordable access to molecular binding analytics.

HEMEX and youEngineering announce strategic partnership

We’re thrilled to announce an exciting new partnership between HEMEX and YouEngineering, a software engineering company which aims to foster digital progress. Our latest partnership enables us to provide healthcare start-ups with a new range of digital packages to guarantee our clients the best results in mobile app, software development, and web design.

HEMEX and Avanti Europe announce new partnership

HEMEX is delighted to announce an exciting new partnership with Avanti Europe. The
Avanti Europe team is a specialist consultancy and expert knowledge provider. This
partnership will allow us to complete the range of products we provide to healthcare start-ups to ensure we continue offering excellent support within the life science industry.